Life Science Investing PMV Pharmaceuticals Announces Promising Rezatapopt Monotherapy Interim Data From PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation
Harvest Gold Provides Update on its Ongoing Drill Program at Mosseau and Has Completed its High-Resolution Airborne Magnetic Survey of Mosseau and Labelle
